CN Patent

CN102675281A — 3-(4-氨基-1-氧代-1,3 二氢-异吲哚-2-基)-哌啶-2,6-二酮的多晶型物

Assigned to Celgene Corp · Expires 2012-09-19 · 14y expired

What this patent protects

公开了3-(4-氨基-l-氧代-1，3二氢-异吲哚-2-基)-哌啶-2，6-二酮的多晶型物。还公开了含有这种多晶型物的组合物，制备这种多晶型物的方法以及其使用方法。

USPTO Abstract

公开了3-(4-氨基-l-氧代-1，3二氢-异吲哚-2-基)-哌啶-2，6-二酮的多晶型物。还公开了含有这种多晶型物的组合物，制备这种多晶型物的方法以及其使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102675281A
Jurisdiction
CN
Classification
—
Expires
2012-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Celgene Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.